Identive Group, Inc. — FY 2012 Form 10-K
Reporting period: Fiscal year ended December 31, 2012; filed March 19, 2013. Although the request identifies INVE Technologies, Inc., the filing names Identive Group, Inc. as the registrant (NASDAQ: INVE). This is an annual report, not a standalone fourth-quarter filing.
Business context
Identive provides secure-identification products, systems and services, including smart-card readers, RFID/NFC products, access-control systems, credential management and cashless-payment solutions. Its two segments are Identity Management and ID Products. Identity Management generated 57% of 2012 revenue; ID Products generated 43%. The 2012 results include the acquired payment solution business from January 30, 2012, so comparisons are affected by acquisitions.
Key financial results
| Metric | FY 2012 | FY 2011 |
|---|---|---|
| Revenue | $94.6 million | $102.7 million |
| Gross profit / margin | $38.4 million / 40.7% | $42.8 million / 41.7% |
| Operating loss | $59.0 million | $10.4 million |
| Consolidated net loss | $53.6 million | $10.2 million |
| Net loss attributable to Identive stockholders | $50.3 million | $9.8 million |
| Net loss per share | $0.84 | $0.18 |
| Cash used in operating activities | $12.2 million | $4.6 million |
Revenue fell 8%; management reported organic revenue declined 14% after excluding approximately $6.2 million of incremental revenue from acquired businesses. Product revenue decreased 13% to $77.7 million, while services revenue rose 26% to $16.9 million. Segment revenue declined 4% in Identity Management and 13% in ID Products. Fourth-quarter revenue was $26.6 million versus $27.9 million a year earlier; fourth-quarter gross profit was $10.4 million, and the company reported consolidated net income of $0.5 million.
The FY 2012 operating loss included $27.1 million of goodwill impairment and $24.8 million of long-lived-asset impairment. The company also recorded a $5.7 million operating credit from reducing acquisition earn-out estimates. These items materially affect comparison of reported losses. Base operating expenses (R&D, selling and marketing, and G&A) were down 4% for the year and 22% in Q4 year over year; R&D spending nevertheless increased 23% to $8.7 million.
Financial position, liquidity and debt
- Cash and cash equivalents were $7.4 million at year-end, down from $17.2 million. Working capital was negative $0.1 million, versus positive $16.7 million a year earlier; current assets were $37.2 million and current liabilities $37.3 million.
- Operating cash outflow was $12.2 million. Investing activities used $2.7 million; financing activities provided $4.9 million, including $6.9 million net proceeds from the secured loan.
- Financial liabilities totaled $14.3 million, including $8.6 million outstanding under the secured note. The Hercules loan is secured by substantially all company assets, bears interest at the greater of prime plus 7.75% or 11%, and matures November 2015. It includes financial covenants; an amendment in March 2013 reduced the monthly EBITDA requirement for January–May 2013.
- Contractual obligations totaled $42.7 million, including $18.7 million due within one year. The filing separately reports a related-party liability of $7.7 million on the balance sheet and approximately $10.5 million of gross contractual payments.
Outlook, risks and unusual items
Management said it expected revenue growth and improved margins over the following 12 months and believed available resources, expected operating cash flow, cost savings and available borrowings would fund operations and capital needs for that period. It gave no numerical revenue or earnings guidance in the provided filing text. Management also said preliminary results for the first two months of 2013 had been hurt by U.S. government sequestration and could cause Q1 results to miss guidance or market expectations; Q1 is typically the company’s weakest quarter.
The auditor and management disclosed substantial doubt about the company’s ability to continue as a going concern, citing recurring losses, negative operating cash flows, accumulated deficit of $286.0 million and liquidity pressure. Management’s plans depend on achieving revenue and margin improvements, cost reductions, better working capital and potentially obtaining additional financing or disposing of noncore assets; success is not assured.
- Government budget delays and sequestration, weak European demand and delayed customer projects affected sales. The company cited the absence of German national-ID program orders that had generated $7.6 million in 2011.
- Goodwill and long-lived-asset impairments followed a decline in share price and reduced forecasts. Further impairment charges remain possible.
- Disclosure controls and internal control over financial reporting were deemed ineffective at year-end due to insufficient review and oversight of complex and non-routine transactions. The revenue-recognition weakness was deemed remediated, but other remediation remained incomplete; management expected to address it in the first half of 2013.
- The filing reports a prior-period pension-accounting correction deemed immaterial. It also says the Q2 2012 income-tax benefit was understated by approximately $5.5 million, overstating Q2 net loss by that amount; the Audit Committee concluded the adjustment was not material. Quarterly results were to be restated in later 10-Q filings.
- Other stated risks include covenant defaults, additional financing needs and dilution, customer and supplier credit risk, foreign-exchange exposure, intense competition, product and cybersecurity risks, and dependence on government programs. No material non-ordinary-course legal proceeding was reported.
Most important facts for investors to verify
- Whether cash generation, working capital and financing access were sufficient after year-end, and whether the company remained in compliance with Hercules loan covenants.
- Actual 2013 revenue, margins and cash use versus management’s stated assumptions, including the impact of sequestration and government project timing.
- Completion and independent validation of internal-control remediation, and the final presentation of restated quarterly figures.
- Whether acquired businesses were integrated successfully and whether further impairments, earn-out changes or restructuring charges occurred.
- The distinction between consolidated net loss ($53.6 million) and loss attributable to Identive stockholders ($50.3 million), and the effect of potential share issuance and warrants on dilution.